| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |